AI Terminal
Natwest Group PLC
Transaction in Own Shares • Mar 4, 2024
4644_rns_2024-03-04_7ba7a8c4-d78a-4820-a997-2ed2a9ec7984.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 5369F
NatWest Group plc
04 March 2024
| NatWest Group plc | ||||||
| 4 March 2024 | ||||||
| Transaction in Own Shares | ||||||
| NatWest Group plc (the 'Company') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS') across two transactions, Transaction 1 and Transaction 2 (together the 'Transactions'). | ||||||
| The purchases form part of the Company's existing share buyback programmes, with Transaction 1 purchases effected pursuant to the instructions issued by the Company to UBS on 28 July 2023, as announced on 31 July 2023 and Transaction 2 purchases effected pursuant to the instructions issued by the Company to UBS on 16 February 2024, as announced on 19 February 2024. | ||||||
| Aggregated information relating to the Transactions is set out in the tables below. | ||||||
| Transaction 1: | ||||||
| Date of purchase | Number of Ordinary Shares purchased | Highest price paid: (GBp) | Lowest price paid: (GBp) | Volume weighted average price paid per share (GBp) | Venue | |
| 04 March 2024 | 0 | 0.00 | 0.00 | 0.0000 | LSE | |
| 04 March 2024 | 0 | 0.00 | 0.00 | 0.0000 | CHIX | |
| 04 March 2024 | 0 | 0.00 | 0.00 | 0.0000 | BATE | |
| Transaction 2: | ||||||
| Date of purchase | Number of Ordinary Shares purchased | Highest price paid: (GBp) | Lowest price paid: (GBp) | Volume weighted average price paid per share (GBp) | Venue | |
| 04 March 2024 | 3,621 | 247.00 | 246.70 | 246.9000 | LSE | |
| 04 March 2024 | 1,520 | 246.70 | 246.70 | 246.7000 | CHIX | |
| 04 March 2024 | 3,527 | 247.10 | 246.70 | 246.8887 | BATE | |
| * Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share | ||||||
| The Company intends to cancel all of the Ordinary Shares repurchased under the Transactions. Following the settlement of the transactions, the Company will hold 174,092,465 Ordinary Shares in treasury and have 8,750,711,863 Ordinary Shares in issue (excluding treasury shares). | ||||||
| Further information: | ||||||
| Investor Relations | ||||||
| + 44 (0)207 672 1758 | ||||||
| Media Relations | ||||||
| +44 (0)131 523 4205 | ||||||
| Legal Entity Identifier: 2138005O9XJIJN4JPN90 | ||||||
| Details of the Transactions | ||||||
| In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programmes relating to the Transactions is detailed below: | ||||||
| Transaction 2: | ||||||
| Transaction Date | Time | Time Zone | Volume (shares) | Price (GBp) | Trading Venue | MatchID |
| 04 March 2024 | 08:00:30 | BST | 1290 | 246.70 | BATE | 1741638 |
| 04 March 2024 | 08:00:30 | BST | 600 | 247.00 | BATE | 1741636 |
| 04 March 2024 | 08:00:30 | BST | 345 | 246.90 | BATE | 1741634 |
| 04 March 2024 | 08:00:30 | BST | 160 | 246.90 | BATE | 1741632 |
| 04 March 2024 | 08:00:33 | BST | 448 | 247.10 | BATE | 1741751 |
| 04 March 2024 | 08:00:34 | BST | 684 | 247.00 | BATE | 1741758 |
| 04 March 2024 | 08:01:40 | BST | 1520 | 246.70 | CHIX | 1743158 |
| 04 March 2024 | 08:00:32 | BST | 806 | 247.00 | LSE | 1741697 |
| 04 March 2024 | 08:00:34 | BST | 887 | 247.00 | LSE | 1741760 |
| 04 March 2024 | 08:00:35 | BST | 773 | 246.90 | LSE | 1741806 |
| 04 March 2024 | 08:00:40 | BST | 471 | 246.70 | LSE | 1741942 |
| 04 March 2024 | 08:00:40 | BST | 617 | 246.80 | LSE | 1741940 |
| 04 March 2024 | 08:00:42 | BST | 67 | 246.70 | LSE | 1741975 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSQKQBQOBKDONK